Edition:
United Kingdom

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

5.46USD
4:35pm BST
Change (% chg)

$-0.07 (-1.27%)
Prev Close
$5.53
Open
$5.56
Day's High
$5.60
Day's Low
$5.41
Volume
4,016
Avg. Vol
34,571
52-wk High
$18.17
52-wk Low
$5.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.471
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.312
Jun '17 0.00 -1.488
Mar '17 0.00 -0.279
FY 2016 Dec '16 0.00 -0.302
Sep '16 0.00 -0.516
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.57 -0.54 -0.59 --
Quarter Ending Sep-18 3 -0.58 -0.52 -0.61 --
Year Ending Dec-18 3 -2.23 -2.09 -2.35 --
Year Ending Dec-19 3 -2.38 -2.31 -2.48 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.19 32.74
P/E High - Last 5 Yrs. -- 40.82 45.73
P/E Low - Last 5 Yrs. -- 20.23 24.23
Beta -- 0.79 0.88
Price to Sales (TTM) -- 7.40 5.71
Price to Book (MRQ) -- 13.07 5.37
Price to Tangible Book (MRQ) -- 26.47 6.94
Price to Cash Flow (TTM) -- 21.76 23.32
% Owned Institutions -- 4.99 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.03 1.50
Dividend Yield - 5 Year Avg -- 1.20 1.51
Dividend 5 Year Growth Rate -- 16.81 5.32
Payout Ratio(TTM) -- 30.00 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.43 7.89
Sales (TTM) vs TTM 1 Yr. Ago -- 2.03 5.68
Sales - 5 Yr. Growth Rate -- 8.76 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 48.75 19.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 19.27 10.78
Capital Spending - 5 Yr. Growth Rate -- 8.67 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.19
Current Ratio (MRQ) -- 3.12 2.98
LT Debt to Equity (MRQ) -- 30.29 12.19
Total Debt to Equity (MRQ) -- 36.88 16.46
Interest Coverage (TTM) -- 16.02 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.82 54.46
Gross Margin - 5 Yr. Avg. -- 58.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 23.26 10.98
Operating Margin (TTM) -- 17.75 4.74
Operating Margin - 5 Yr. Avg. -- 16.02 6.41
Pre-Tax Margin (TTM) -- 17.49 5.58
Pre-Tax Margin - 5 Yr. Avg. -- 16.26 6.83
Net Profit Margin (TTM) -- 13.43 1.88
Net Profit Margin - 5 Yr. Avg. -- 11.35 3.10
Effective Tax Rate (TTM) -- 22.58 23.04
Effective Tax Rate - 5 Yr. Avg. -- 28.85 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 26,739,483 846,855,612
Net Income/Employee (TTM) -- 3,194,115 99,619,380
Receivable Turnover (TTM) -- 5.08 5.78
Inventory Turnover (TTM) -- 3.15 3.35
Asset Turnover (TTM) -- 0.77 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.45 10.95
Return on Assets - 5 Yr. Avg. -- 9.09 12.32
Return on Investment (TTM) -- 13.89 14.38
Return on Investment - 5 Yr. Avg. -- 11.76 16.11
Return on Equity (TTM) -- 16.72 16.08
Return on Equity - 5 Yr. Avg. -- 14.17 17.41

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.18%
# of Holders: 58
Total Shares Held: 14,867,052
3 Mo. Net Change: 578,043
# New Positions: 33
# Closed Positions: 9
# Increased Positions: 44
# Reduced Positions: 12
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.